Auditory Neuropathy Spectrum Disorder Dynamics

Auditory neuropathy spectrum disorder (ANSD) represents a heterogeneous group of hearing impairments in which neural transmission of sound is disrupted even though the mechanical amplification provided by outer hair cells remains largely intact. The disorder can arise from dysfunction at the level of inner hair cells, synaptic transmission to spiral ganglion neurons or within the auditory nerve itself, leading to variable presentations of speech perception difficulty disproportionate to pure-tone thresholds. The temporal dynamics of ANSD encompass congenital forms associated with gene variants, as well as postlingual-onset and progressive phenotypes. Advances in electrophysiological assessment—such as otoacoustic emissions, cochlear microphonic recordings and auditory brainstem responses—have refined early diagnosis, while diffusion-weighted magnetic resonance imaging now offers in vivo markers of auditory nerve fibre integrity. Genetic discoveries continue to expand the spectrum of molecular causes, revealing both presynaptic and postsynaptic loci of lesion and guiding personalised interventions. Treatment strategies range from aided devices for mild-to-moderate loss to cochlear implantation in profound cases, with outcomes influenced by the site of lesion and extent of neural degeneration. Collectively, these developments underscore the dynamic interplay between molecular pathogenesis, diagnostic innovation and therapeutic decision-making in ANSD, with implications for newborn screening, rehabilitation timing and emerging gene therapies.

Research from Nature Portfolio

Recent work has identified a de novo variant in the ATP1A3 gene as a cause of sporadic, postlingual-onset progressive ANSD. Functional analyses revealed that this variant disrupts ion-pump activity at the synapse between inner hair cells and afferent nerve fibres, leading to gradual auditory synaptopathy. Affected individuals exhibited characteristic auditory brainstem response abnormalities alongside preserved otoacoustic emissions, and early cochlear implantation in one case yielded rapid post-operative improvement in speech perception. This finding highlights ATP1A3 as both a contributor to progressive ANSD and a predictive biomarker for favourable implant outcomes.

Auditory Neuropathy Spectrum Disorder Dynamics publication trend

The graph below shows the total number of articles in auditory neuropathy spectrum disorder dynamics across all publications each year (not limited to Nature Index journals).

Technical terms

Auditory neuropathy spectrum disorder (ANSD): A form of hearing impairment characterised by preserved outer hair-cell function but impaired neural transmission along the auditory pathway.

Otoacoustic emissions (OAEs): Sounds generated by outer hair cells in response to auditory stimuli, used to assess cochlear function.

Auditory brainstem response (ABR): An evoked-potential test measuring neural activity along the auditory nerve and brainstem in response to sound.

Apparent fibre density (AFD): A diffusion-MRI metric estimating the density of nerve fibres in a given tract, reflecting axonal integrity.

Inner hair cell (IHC): Sensory receptor cell in the cochlea that transduces mechanical sound vibrations into neural signals.

References

1. A dominant variant in apoptosis-related gene XKR8 is relevant to hereditary auditory neuropathy. Journal of Translational Medicine (2023).
2. Diffusion‐Weighted Magnetic Resonance Imaging: A Diagnostic Tool for Auditory (Axonal) Neuropathy. European Journal of Neurology (2025).
3. The natural history, clinical outcomes, and genotype–phenotype relationship of otoferlin-related hearing loss: a systematic, quantitative literature review. Human Genetics (2023).
4. ATP1A3 mutations can cause progressive auditory neuropathy: a new gene of auditory synaptopathy. Scientific Reports (2017).
5. Auditory Neuropathy Spectrum Disorders: From Diagnosis to Treatment: Literature Review and Case Reports. Journal of Clinical Medicine (2020).